Ignite Creation Date:
2026-03-26 @ 3:21 PM
Ignite Modification Date:
2026-04-16 @ 8:37 PM
Study NCT ID:
NCT05782127
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2026-03-13
First Post:
2023-02-23
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Oral Azacitidine Combined With Venetoclax in Previously Untreated Higher-risk Myelodysplastic Syndromes
Sponsor:
Groupe Francophone des Myelodysplasies
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-12-06
Start Date Type:
ACTUAL
Primary Completion Date:
2025-12-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2028-11
Completion Date Type:
ESTIMATED
First Submit Date:
2023-02-23
First Submit QC Date:
None
Study First Post Date:
2023-03-23
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2026-03-11
Last Update Post Date:
2026-03-13
Last Update Post Date Type:
ACTUAL